Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-22-003785

See Remarks acquired 1,715 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rhode Peter See Remarks 2022-01-14 Option exercise +1,714 $0.21 $360 48,499 D
Rhode Peter See Remarks 2022-01-14 Option exercise +1 $0.14 $0 48,500 D
Derivatives
Rhode Peter See Remarks 2022-01-14 Option exercise · Stock Option Grant (Right to Buy) −1,714 6,857 D
Rhode Peter See Remarks 2022-01-14 Option exercise · Stock Option Grant (Right to Buy) −1 51,427 D
Loading xslF345X03/doc4.xml…